Rigel Pharmaceuticals (RIGL) Earnings Date, Estimates & Call Transcripts $27.61 -0.27 (-0.97%) (As of 11/29/2024 05:27 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Rigel Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Rigel Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataRIGL Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RIGL Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Brownstone ResearchMedia Is Mocking Elon, But Wait Until They See This DemoElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. Rigel Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242-$0.03-$0.01-$0.02Q2 20242-$0.04-$0.03-$0.04Q3 20242-$0.21-$0.04-$0.13Q4 20242-$0.28$0.06-$0.11FY 20248-$0.56-$0.02-$0.29Q1 20251$0.01$0.01$0.01Q2 20251$0.00$0.00$0.00Q3 20251$0.02$0.02$0.02Q4 20251$0.04$0.04$0.04FY 20254$0.07$0.07$0.07 Rigel Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 3/4/2025(Estimated)------- 8/6/2024Q2 2024-$0.37-$0.06+$0.31-$0.06$32.38M$36.84M 5/7/2024Q1 2024-$0.30-$0.50 -$0.20-$0.05$31.28M$29.53M 11/7/2023Q3 2023-$0.70-$0.30+$0.40-$0.03$27.83M$28.13M 8/1/2023Q2 2023-$0.80-$0.40+$0.40-$0.04$26.02M$26.89M 5/2/2023Q1 2023-$0.90-$0.80+$0.10-$0.08$24.29M$26.07M 3/7/2023Q4 2022-$0.70$0.10+$0.80$0.01$37.55M$51.28M Get the Latest News and Ratings for RIGL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Rigel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Rigel Pharmaceuticals Earnings - Frequently Asked Questions When is Rigel Pharmaceuticals's earnings date? Rigel Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 4th, 2025 based off last year's report dates. Learn more on RIGL's earnings history. How much revenue does Rigel Pharmaceuticals generate each year? Rigel Pharmaceuticals (NASDAQ:RIGL) has a recorded annual revenue of $116.88 million. How much profit does Rigel Pharmaceuticals generate each year? Rigel Pharmaceuticals (NASDAQ:RIGL) has a recorded net income of -$25.09 million. RIGL has generated $0.14 earnings per share over the last four quarters. What is Rigel Pharmaceuticals's price-to-earnings ratio? Rigel Pharmaceuticals (NASDAQ:RIGL) has a trailing price-to-earnings ratio of 197.23 and a forward price-to-earnings ratio of 162.41. What is Rigel Pharmaceuticals's EPS forecast for next year? Rigel Pharmaceuticals's earnings are expected to grow from $0.17 per share to $0.92 per share in the next year, which is a 441.18% increase. ` More Earnings Resources from MarketBeat Related Companies Dynavax Technologies Earnings Date BioCryst Pharmaceuticals Earnings Date Novavax Earnings Date Myriad Genetics Earnings Date Innoviva Earnings Date OPKO Health Earnings Date Ironwood Pharmaceuticals Earnings Date Emergent BioSolutions Earnings Date Sangamo Therapeutics Earnings Date Codexis Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings Report Media Is Mocking Elon, But Wait Until They See This Demo (Ad)Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. This page (NASDAQ:RIGL) was last updated on 12/1/2024 by MarketBeat.com Staff From Our PartnersThe latest trend in real estateThese vacation homes are often expensive to maintain and vacant 90% of the year. But thanks to co-ownership, t...Pacaso | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredBofA is watching for a market topU.S. tech stocks have soared so high for so long that they're no longer just minting new millionaires... Th...Chaikin Analytics | SponsoredPaypal, Tesla, SpaceX… Elon's next project is bigger than them allIn February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | Sponsored***TODAY ONLY*** Is this Trump’s Favorite Coin?Donald Trump just emphatically became America's first crypto president. Trump plans to make America, "the...Weiss Ratings | SponsoredThis Crisis Could Be Worse Than 2008Underneath the surface, cracks are forming. Cracks that threaten to shatter everything we know. America ...Behind the Markets | SponsoredYou’re invited! See my NEWEST trading strategyThis could easily be the most lucrative new trading strategy of 2025... So you’re not going to want to miss...Monument Traders Alliance | SponsoredBlack Friday: 59% dividend from Bitcoin (No Crypto Needed)Get a 59% Dividend from Bitcoin—No Crypto Required! Our Black Friday special reveals the "Bitcoin Income Va...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rigel Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rigel Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
